Small-Cap Firms Were Last Week’s Top Performers. In this article, we are going to take a look at where Fold Holdings, Inc.

Q4 2024 Earnings Call Transcript March 6, 2025 BrightSpring Health Services, Inc. Common Stock beats earnings expectations. Reported EPS is $0.22, expectations were $0.19. Operator: Good day, and ...

Dan Gilbert's Rocket Companies plans to buy the online real estate brokerage firm Redfin, a $1.75 billion deal that would expand Rocket's presence in all things residential real estate. The all-stock ...

MicroStrategy on Monday said it plans to sell up to $21 billion of its 8% Series A perpetual strike preferred stock in an at-the-market program, similar to a program to sell up to $21 billion in ...

The upfront cash payment of $4.10 per share of common stock represents a premium of around 66% to Checkpoint’s closing share ...

On March 7, 2025, Volcon ePowersports (”Volcon” or the “Company”) (NASDAQ:VLCN), a provider of electric vehicles today announced that its Board of Directors has authorized a share repurchase program, ...

Each share of Redfin common stock will be exchanged for 0.7926 shares of Rocket Companies Class A common stock. Based on Friday's closing price for Rocket of $15.77 a share, each Redfin share will be ...

Dave Inc. ("Dave” or the "Company”) (NASDAQ: DAVE), one of the nation's leading neobanks, today announced that its Board of Directors has authorized a share repurchase program to buy back up to $50 ...

Willis Lease Finance Corporation (NASDAQ: WLFC) ("WLFC”) today reported record annual total revenues of $569.2 million and ...

Sun Pharmaceutical Industries and Checkpoint Therapeutics, Inc. (Nasdaq: CKPT) (Checkpoint) today announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an ...

Good day, and welcome to the Genie Energy Limited's Fourth Quarter and Full-Year 2024 Earnings Call. In today's presentation Genie Energy management will discuss Genie's financial and operational ...

Sun Pharma to acquire Checkpoint Therapeutics, expanding innovative portfolio in onco-derm therapy with FDA-approved UNLOXCYT ...